Copyright
©The Author(s) 2017.
World J Gastroenterol. Jul 28, 2017; 23(28): 5187-5195
Published online Jul 28, 2017. doi: 10.3748/wjg.v23.i28.5187
Published online Jul 28, 2017. doi: 10.3748/wjg.v23.i28.5187
Table 2 Glycemic indexes in gastrointestinal cancer patients - Comparison between patients who developed or not venous thromboembolism during chemotherapy
| Whole cohort | Venous thromboembolism | P value1 | ||
| Yes (n = 34) | No (n = 308) | |||
| Glycemia (mg/dL), mean ± SD (range) | 107 ± 38 (51-415) | 122 ± 53 (60-339) | 105 ± 36 (51-415) | 0.019 |
| Insulinemia (μIU/mL), median (IQR) | 12.5 (8.8-20.1) | 17.2 (11.9-24.5) | 11.6 (8.7-18.6) | 0.016 |
| HOMA index, median (IQR) | 3.0 (2.0-5.6) | 4.8 (3.0-8.1) | 2.8 (2.0-4.9) | 0.006 |
| HbA1c (%), mean ± SD (range) | 6.1 ± 0.8 (4.3-13.0) | 6.2 ± 0.6 (5.2-8.0) | 6.1 ± 0.8 (4.3-13.0) | 0.436 |
- Citation: Guadagni F, Riondino S, Formica V, Del Monte G, Morelli AM, Lucchetti J, Spila A, D’Alessandro R, Della-Morte D, Ferroni P, Roselli M. Clinical significance of glycemic parameters on venous thromboembolism risk prediction in gastrointestinal cancer. World J Gastroenterol 2017; 23(28): 5187-5195
- URL: https://www.wjgnet.com/1007-9327/full/v23/i28/5187.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i28.5187